We are live on ! Find out more
ICCM icon

IceCure Medical

12 hedge funds and large institutions have $120K invested in IceCure Medical in 2024 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.4% less ownership

Funds ownership: 0.62% → 0.22% (-0.4%)

29% less funds holding

Funds holding: 17 → 12 (-5)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

56% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 9

75% less capital inflows, than outflows

Capital inflows: $65.9K | Capital outflows: $266K

Holders
12
Holders Change
-5
Holders Change %
-29.41%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
1
Reduced
2
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

ICCM Hedge Fund Activity: Q1 2024 in Review

12 of the 6,969 institutional investors tracked by Wall St. Rank reported a position in IceCure Medical (ICCM) for Q1 2024, worth a combined $120K — down 62% from $312K a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of ICCM and 4 opened new positions — a net loss of 5 holders — while 2 trimmed existing stakes and 1 added.

The largest buyer was Geode Capital Management, opening a new position worth an estimated $33.3K. The largest seller was Citadel Advisors, exiting entirely with an estimated $54.7K sold.

  • 12 institutional investors held IceCure Medical (ICCM) as of Q1 2024, down from 17 in Q4 2023.
  • Funds reported $120K of IceCure Medical stock for Q1 2024, down 62% quarter-over-quarter.
  • 4 funds opened new IceCure Medical positions in Q1 2024 and 9 closed out, a net change of -5 holders.
  • The largest IceCure Medical buyer in Q1 2024 was Geode Capital Management, an estimated $33.3K added.
  • The largest IceCure Medical seller in Q1 2024 was Citadel Advisors, an estimated $54.7K sold.

Based on aggregated 13F filings for Q1 2024.